HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liang Zeng Selected Research

CX-6258

3/2020PIM1 inhibitor synergizes the anti-tumor effect of osimertinib via STAT3 dephosphorylation in EGFR-mutant non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liang Zeng Research Topics

Disease

63Neoplasms (Cancer)
06/2022 - 08/2003
33Neoplasm Metastasis (Metastasis)
02/2022 - 01/2011
18Nasopharyngeal Carcinoma
06/2022 - 11/2002
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 12/2017
12Adenocarcinoma of Lung
03/2022 - 01/2018
12Pain (Aches)
08/2018 - 01/2011
8Carcinoma (Carcinomatosis)
06/2022 - 11/2006
8Inflammation (Inflammations)
05/2022 - 01/2020
7Breast Neoplasms (Breast Cancer)
06/2022 - 02/2016
7Lung Neoplasms (Lung Cancer)
01/2022 - 08/2003
7Carcinogenesis
01/2019 - 02/2007
5Brain Neoplasms (Brain Tumor)
01/2022 - 12/2011
4Chronobiology Disorders (Circadian Rhythm Disorder)
11/2022 - 11/2021
4Infections
06/2022 - 04/2012
4Glioblastoma (Glioblastoma Multiforme)
03/2022 - 04/2014
4Colitis
09/2021 - 11/2019
4Lymphatic Metastasis
08/2019 - 07/2007
4Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 12/2014
4Glioma (Gliomas)
10/2017 - 09/2009
4Prion Diseases (Transmissible Spongiform Encephalopathies)
12/2016 - 01/2015
4Chronic Disease (Chronic Diseases)
08/2014 - 10/2011
3Disease Progression
03/2022 - 01/2020
3Colonic Neoplasms (Colon Cancer)
01/2013 - 04/2011
2Obesity
11/2022 - 11/2021
2Epistaxis (Nosebleed)
06/2022 - 05/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2022 - 03/2013
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 09/2021
2COVID-19
09/2021 - 01/2021
2Hyperplasia
01/2021 - 06/2013
2Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2021
2Adenocarcinoma
06/2020 - 03/2018
2Nausea
11/2018 - 03/2018
2Vomiting
11/2018 - 03/2018
2Scrapie
12/2016 - 01/2015
2Reperfusion Injury
01/2015 - 01/2015
2Nasopharyngitis
11/2014 - 06/2011
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2014 - 09/2012
2Lung Diseases (Lung Disease)
04/2012 - 08/2011
1Hypothyroidism
07/2022
1Thyroiditis
07/2022
1Hyperlipidemias (Hyperlipidemia)
07/2022

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2004
13Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2011
9TeaIBA
11/2022 - 01/2020
8CrizotinibIBA
03/2022 - 01/2018
6Tyrosine Kinase InhibitorsIBA
01/2022 - 01/2018
6ErbB Receptors (EGF Receptor)IBA
01/2022 - 09/2009
6Messenger RNA (mRNA)IBA
09/2020 - 04/2011
5Cisplatin (Platino)FDA LinkGeneric
03/2022 - 09/2007
5Prion ProteinsIBA
12/2016 - 01/2015
4RNA (Ribonucleic Acid)IBA
01/2022 - 12/2020
4Biological ProductsIBA
09/2021 - 05/2007
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2020 - 08/2015
3LipidsIBA
03/2022 - 07/2015
3Phosphotransferases (Kinase)IBA
01/2022 - 09/2009
3Indicators and Reagents (Reagents)IBA
01/2022 - 03/2011
3AfatinibIBA
01/2021 - 01/2018
3Pharmaceutical PreparationsIBA
01/2020 - 11/2002
3Analgesics (Analgesic Drugs)IBA
07/2013 - 06/2011
3Membrane Proteins (Integral Membrane Proteins)IBA
07/2008 - 08/2004
2Bile Acids and Salts (Bile Acids)IBA
05/2022 - 11/2021
2PhytochemicalsIBA
05/2022 - 02/2022
2PolyphenolsIBA
03/2022 - 01/2020
2Transcription Factors (Transcription Factor)IBA
01/2022 - 04/2012
2Anaplastic Lymphoma KinaseIBA
01/2022 - 01/2022
2LigandsIBA
01/2022 - 01/2019
2Bevacizumab (Avastin)FDA Link
10/2021 - 01/2020
2Dextran SulfateIBA
09/2021 - 01/2020
2anlotinibIBA
09/2021 - 06/2020
2flotillinsIBA
04/2020 - 07/2015
2osimertinibIBA
03/2020 - 01/2018
2CytokinesIBA
01/2020 - 08/2018
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019 - 01/2015
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2018 - 07/2013
2AntiemeticsIBA
11/2018 - 03/2018
2ParaffinIBA
10/2018 - 04/2018
2Telomerase (Telomerase Reverse Transcriptase)IBA
12/2017 - 11/2006
2PrionsIBA
12/2016 - 08/2014
2Temozolomide (Temodar)FDA LinkGeneric
02/2015 - 04/2014
2Cadherins (E-Cadherin)IBA
09/2014 - 09/2012
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2013 - 04/2005
2Caspase 3 (Caspase-3)IBA
07/2008 - 11/2006
2Epstein-Barr virus EBV-associated membrane antigenIBA
02/2008 - 06/2003
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
04/2005 - 06/2003
2Tetracycline (Achromycin)FDA LinkGeneric
08/2004 - 07/2004
1cinnabarinic acidIBA
11/2022
1AutoantibodiesIBA
07/2022
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
07/2022
1AGRO 100IBA
06/2022
1ElementsIBA
06/2022

Therapy/Procedure

33Radiotherapy
06/2022 - 09/2006
24Therapeutics
06/2022 - 08/2003
12Drug Therapy (Chemotherapy)
06/2020 - 09/2007
7Palliative Care (Palliative Therapy)
08/2014 - 10/2011
3Percutaneous Collagen Induction
01/2019 - 01/2015
3Aftercare (After-Treatment)
07/2013 - 08/2003
2Neoadjuvant Therapy
04/2022 - 03/2018
2Ligation
09/2020 - 08/2018
2Chemoradiotherapy
01/2010 - 04/2008
2Endoscopes
12/2009 - 01/2009